[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] As thousands of Xarelto injury lawsuits continue to move forward through the court system, a new… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] The lawyers at Saiontz & Kirk, P.A. represent individuals throughout the U.S. who are pursuing a… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] Amid continuing concerns about the risk of uncontrollable bleeding on Xarelto and the lack of an… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] With a growing number of Xarelto injury lawsuits continuing to be filed in U.S. District Courts… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] While Xarelto has been promoted as a superior alternative to warfarin, with the drug makers claiming… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] UPDATE 12/12/2014: Following a hearing before the U.S. JPML on December 4, an order was issued… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] Although Xarelto has been promoted as a superior alternative to warfarin (Coumadin), because it is easier… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] In an effort to maximize profits from their new generation blood thinner Xarelto, Johnson & Johnson… Read More
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] The product liability lawyers at Saiontz & Kirk, P.A. are now providing free consultations and claim… Read More
A petition has been filed in federal court calling for the consolidation of all lawsuits over bleeding problems with Pradaxa as part of a multidistrict litigation, or MDL, where the cases would be centralized before one judge for coordinated handling during pretrial proceedings. While many people… Read More
